Skip to main content
TipRanks
Go Ultimate75% OFF

DEAN PETKANAS Insider Profile

4 Followers

DEAN PETKANAS, former CEO, Director, Ten Percent Owner at Neuropathix, holds 23.15M shares in Neuropathix (Ticker: NPTX).

DEAN PETKANAS's Trading History

NPTX
Neuropathix
Jun 13, 2022―Uninformative Sell4.00K$324.09K
NPTX
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 13, 2022Informative Sell$6.40K320,000$0.02―
Jun 13, 2022Uninformative Sell$4.00K400,000$0.01―
Jun 02, 2022Informative Sell$3.60K180,000$0.02―
Jan 07, 2022Uninformative Sell$0.00550,000$0.00―
Jan 07, 2022Uninformative Sell$11.20K250,000$0.04―

You May Also Like

DEAN PETKANAS insider profile FAQ

What stocks does DEAN PETKANAS hold?
DEAN PETKANAS holds: NPTX stocks.
What was DEAN PETKANAS’s latest transaction?
DEAN PETKANAS’s latest transaction was an Uninformative Sell of $4.00K.
What was DEAN PETKANAS's most profitable transaction?
DEAN PETKANAS’s most profitable transaction was an Informative Sell of NPTX stock on December 3, 2019. The return on the trade was -542.80%.
What is DEAN PETKANAS's role in Neuropathix?
DEAN PETKANAS's role in Neuropathix is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.